In focus
Latest feed
FDA Greenlights Zenbexus: A New Era for Multiple Myeloma Treatment
Elicio Therapeutics Navigates Q2 2026 with Strong Financing and Promising Clinical Signals
Elicio Therapeutics Marks Significant Financial Turnaround and Pivotal Clinical Advances in Latest Quarter
The Great Biotech Bet: Prediction Markets Clash with Medical Ethics
